The Daily Fuckup

The CDC’s already miserable summer turned into yet another public-health spectacle on August 29, 2025, as the fallout from Susan Monarez’s firing kept spreading through the agency and into the larger fight over how the Trump administration is reshaping federal health policy. What might have been described in calmer times as a leadership transition instead looked like a full-blown institutional rupture. Senior departures followed the upheaval, and the people walking out the door did not sound like officials making polite excuses on the way to their next jobs. They sounded angry, skeptical, and in some cases openly contemptuous of the administration now in charge. That alone made clear this was not ordinary turnover at a technical agency that is supposed to run on continuity, trust, and internal confidence.

One of the most visible figures to leave, Demetre Daskalakis, quickly became a symbol of the larger fight. After White House press secretary Karoline Leavitt criticized his use of the phrase “pregnant people,” Daskalakis effectively told her he had heard the complaint and did not care. The exchange was more than a snappy insult dressed up as policy debate. It illustrated how the conflict has moved far beyond staffing questions and into a broader war over language, identity, and who gets to define the terms of federal health guidance. In a normal public-health system, a dispute over wording would be handled as a communications issue, or at most as part of a clinical discussion about audience and accuracy. Here, it became another public proxy fight, with the White House signaling what kind of language it wants scrubbed from government work and departing officials signaling they were not going to apologize for using terms they considered medically and socially appropriate.

That back-and-forth matters because the CDC is not a decorative bureaucracy. It is the federal government’s main early-warning system for outbreaks, vaccine recommendations, disease surveillance, and the kind of technical guidance that state health departments, hospitals, doctors, and parents depend on when they need something firmer than a slogan. When senior leaders are pushed out or decide they can no longer stay, the agency does not just lose names on a masthead. It loses institutional memory, the trust of staff who need to believe leadership is stable, and the ability to respond quickly and coherently when the next health problem arrives. Public-health experts have long warned that turmoil like this can create confusion around vaccines and slow responses to outbreaks, even if the damage does not always show up in dramatic fashion right away. That risk is hard to brush off in a country where measles, respiratory viruses, foodborne illness, and other threats keep reappearing no matter what Washington is fighting about on any given day. If the people responsible for tracking and explaining disease spend their time defending themselves from ideological pressure, the system is already taking on avoidable strain.

Daskalakis’ departure also sharpened the sense that the administration’s conflict with the CDC is not just about management style or different views on personnel. He said the White House was trying to erase transgender people from public life, and the White House response to his language only reinforced the impression that basic medical terminology has become a political battleground. Supporters of the purge can argue that the administration is simply installing leaders who better reflect its priorities, and they may insist that any shake-up of a bureaucracy is an overdue corrective. But that argument still leaves open the practical question that matters most: who is running the agency, what expertise remains in place, and how well can the CDC function while it is being remade in the middle of ongoing public-health risks? At a place like the CDC, competence is not a decorative value or a nice-to-have. It is the core job requirement. That is why critics have treated the latest departures as something more serious than the usual churn in Washington. To them, it looks like an administration willing to treat scientific institutions as extensions of a culture war, even when those institutions are supposed to stand apart from partisan conflict. The result is a health agency that increasingly resembles a battlefield where symbolic victories are being prized over operational reliability.

The immediate consequence is a damaged CDC trying to operate through a leadership vacuum while the White House talks as though the entire episode is just another loyalty test. That does not inspire confidence in state health departments, hospital systems, clinicians, or families trying to decide what guidance they should trust. It also gives Democrats and public-health advocates a simple and damaging critique: this is not reform, it is degradation, and a critical agency is being hollowed out at exactly the wrong moment. The longer-term concern may be slower and less visible, but it could be worse. Trust in public-health institutions is difficult to rebuild once it starts slipping, especially when every fight over vaccines, language, or staffing becomes one more reason for the public to wonder whether the agency is still speaking with one voice. The consequences may not arrive all at once, which is precisely what makes this kind of damage so dangerous. The CDC is still standing, at least on paper, but the question now is whether it can keep doing its actual job while the administration keeps turning it into a political prop.